V
VITL
VITL - Premium Supplements Online
About VITL
Founded in 2015 by Jonathan Relph and Oliver Bolton, VITL operates within the personalized health and wellness market, offering a data-driven approach to nutrition. The company's genesis stems from founder Jonathan Relph's background in finance, where his work with medical technology companies revealed a growing trend of individuals using data from fitness apps to inform their health decisions. This insight, combined with a dissatisfaction for the generic supplements available, inspired the creation of a more personalized and modern nutrition service.
VITL's business model is centered on a direct-to-consumer, subscription-based service, supplemented by a growing retail presence. The company generates revenue by selling personalized vitamin packs, at-home test kits, and a range of formulated supplements. Customers begin with a free five-minute online consultation that assesses their diet, lifestyle, and health goals. Based on this AI-powered analysis, VITL recommends a tailor-made vitamin regimen delivered monthly. For deeper personalization, clients can opt for at-home DNA and blood tests, which analyze various biomarkers like vitamin levels, cholesterol, and genetic predispositions related to nutrient absorption. The results are used to further refine supplement recommendations and provide personalized health advice.
The product suite includes daily vitamin packs, specific supplements for goals like sleep or beauty, and recently, a line of vitamin and protein bars. All supplements are formulated to be non-GMO and free from synthetic fillers, sugar, and gluten. Initially a direct-to-consumer brand, VITL has expanded its reach through partnerships with major UK retailers such as Sainsbury's, Boots, and Holland & Barrett. The company has successfully raised approximately $13.4 million over several funding rounds, with a significant Series A round in February 2022 to fuel product expansion and entry into new markets.
Source: Dealroom company dataAt a glance
- Founded
- 2015
- Headquarters
- London, United Kingdom
- Sector
- Health Tech & Medtech
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed7 investors entered at this stage
Samos Investments
True.
ACF Investors- SDSimon Duffy
Alex Chesterman
Crowdcube
Ornament Health
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about VITL on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See VITL on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.